Melanoma gp100 antibody
Quick Overview for Melanoma gp100 antibody (ABIN630469)
Target
See all Melanoma gp100 (PMEL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Purified
-
Immunogen
- SILV antibody was raised using a synthetic peptide corresponding to a region with amino acids HFLRNQPLTFALQLHDPSGYLAEADLSYTWDFGDSSGTLISRALVVTHTY
-
-
-
-
Application Notes
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SILV Blocking Peptide, (ABIN939113), is also available for use as a blocking control in assays to test for specificity of this SILV antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SILV antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))
-
Alternative Name
- SILV
-
Background
- SILV could be a melanogenic enzyme. It could represent an oncofetal self-antigen that is normally expressed at low levels in quiescent adult melanocytes but overexpressed by proliferating neonatal melanocytes and during tumor growth. Release of the soluble form, ME20-S, it could protect tumor cells from antibody mediated immunity.
-
Molecular Weight
- 70 kDa (MW of target protein)
Target
-